1. Home
  2. MICC vs TECH Comparison

MICC vs TECH Comparison

Compare MICC & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MICC

The Magnum Ice Cream Company N.V. Ordinary Shares

N/A

Current Price

$17.07

Market Cap

12.1B

ML Signal

N/A

Logo Bio-Techne Corp

TECH

Bio-Techne Corp

SELL

Current Price

$72.50

Market Cap

11.4B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
MICC
TECH
Founded
2025
1976
Country
Netherlands
United States
Employees
N/A
N/A
Industry
Specialty Foods
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.1B
11.4B
IPO Year
2025
1995

Fundamental Metrics

Financial Performance
Metric
MICC
TECH
Price
$17.07
$72.50
Analyst Decision
Hold
Hold
Analyst Count
4
13
Target Price
$19.08
★ $70.50
AVG Volume (30 Days)
701.6K
★ 2.8M
Earning Date
10-30-2026
11-04-2026
Dividend Yield
N/A
★ 0.44%
EPS Growth
N/A
★ 152.17
EPS
N/A
★ 1.16
Revenue
N/A
★ $1,215,039,000.00
Revenue This Year
$5.51
$4.35
Revenue Next Year
$3.90
$10.04
P/E Ratio
★ $28.55
$62.46
Revenue Growth
★ N/A
N/A
52 Week Low
$12.94
$43.20
52 Week High
$20.69
$72.69

Technical Indicators

Market Signals
Indicator
MICC
TECH
Relative Strength Index (RSI) 27.35 56.53
Support Level $14.18 $72.36
Resistance Level $18.27 $72.66
Average True Range (ATR) 0.28 0.16
MACD -0.24 -0.04
Stochastic Oscillator 7.34 53.49

Price Performance

Historical Comparison
MICC
TECH

About MICC The Magnum Ice Cream Company N.V. Ordinary Shares

The Magnum Ice Cream Company is a spinoff from Unilever, a pure-play company in manufacturing and selling a broad portfolio of ice-cream brands. The company is a global category leader, operating in 80 countries with around 21% market share. TMICC owns four of the world's five largest ice-cream brands: the Heartbrand (an "umbrella" brand with numerous well-known subbrands, which constitutes around 35% of sales), Magnum (23%), Ben & Jerry's (14%), and Cornetto (9%). The business generates about 65% of its revenue in developed markets, with the balance coming from emerging markets.

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Share on Social Networks: